The Lancet | The best science for better lives
Jan 13, 2025 · Diverse scientific and healthcare workforces promote advancement in human health, fostering innovation and equitable access to quality care. Yet efforts to enhance …
The Lancet: Journal Homepage
6 days ago · Prompted by the 20th anniversary of the 1993 World Development Report, a Lancet Commission revisited the case for investment in health and developed a new framework to achieve dramatic health gains by …
The Lancet, 25 January 2025, Volume 405, Issue 10475, Pages 273 …
6 days ago · Explore the current issue of The Lancet, a world leading medical journal published weekly since 1823
Preparing for the next pandemic - The Lancet
6 hours ago · In a clinic in Guinea, a community health worker is puzzled by the number of people in a village becoming severely ill and reports this to their superior, who notifies the Ministry of …
Announcing the - The Lancet
3 days ago · 5 years since the onset of the COVID-19 pandemic, with SARS-CoV-2 moving to endemicity and new threats such as H5N1 influenza, mpox, and Marburg virus spilling into …
Undervaccination and severe COVID-19 outcomes - The Lancet
6 days ago · There might have been fewer severe COVID-19 outcomes in 4 months if those who were undervaccinated had been fully vaccinated; extended over 1 year, 0·072% less of the …
Antibody testing to predict SARS-CoV-2 risk in ... - The Lancet
The development of adaptive immunity to SARS-CoV-2 (in the shape of antibody, B, and T cells) is associated with protection against infection and severe disease, regardless of whether this …
The Lancet - All Issues
Jan 4, 2025 · The Lancet; The Lancet Child & Adolescent Health; The Lancet Diabetes & Endocrinology; The Lancet Digital Health; The Lancet Gastroenterology & Hepatology
About The Lancet medical journal
A world-leading general medical journal. Every week, The Lancet publishes the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health. Since Thomas Wakley founded The Lancet in …
Insights into the future of first-line advanced hepatocellular ...
Jan 22, 2025 · Atezolizumab plus bevacizumab is the standard of care for patients with advanced hepatocellular carcinoma. Building on the impressive results of IMBrave150,1 the phase 1b–2 MORPHEUS-Liver trial2 compared another dual immune checkpoint inhibitor regimen, the combination of atezolizumab plus bevacizumab with the first-in-class anti-TIGIT antibody …